230 results on '"Gallego, O"'
Search Results
2. A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
3. Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
4. Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients
5. The usefulness of 18F-fluorocholine PET/CT in the detection of recurrence of central nervous system primary neoplasms
6. Characterization of the Carnian Pluvial Episode in the Argana Basin (Western High Atlas, Morocco): An approach based on sedimentology, clay mineralogy and paleosols
7. CONIFER FOSSIL WOODS FROM THE LATE JURASSIC–EARLY CRETACEOUS (SOLARI/BOTUCATÚ FORMATION) OF THE PARAJE TRES CERROS (CORRIENTES PROVINCE), NORTHEAST ARGENTINA
8. Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area
9. A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma
10. Structure-based learning to model complex protein-DNA interactions and transcription-factor co-operativity incis-regulatory elements
11. OPTIMIZATION OF THE CROSSFLOW MICROFILTRATION OF ARAZÁ JUICE (Eugenia stipitata) UNDER DIFFERENT OPERATION MODES OPTIMIZACIÓN DEL PROCESO DE MICROFILTRACIÓN TANGENCIAL DE JUGO DE ARAZÁ (Eugenia stipitata) A DIFERENTES MODOS DE OPERACIÓN
12. P.0302 Polymorphisms in dopamine d2 receptor gene are associated with obesity in antipsychotic treatment patients: no relationship with eating habits changes
13. Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study
14. 344MO Experience of GEINO (Spanish cooperative group for research in neuro-oncology) oncologists in the management of adult medulloblastoma
15. RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma
16. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
17. Experience of GEINO (Spanish cooperative group for research in neuro-oncology) oncologists in the management of adult medulloblastoma
18. Extended-schedule dose-dense temozolomide in refractory gliomas
19. Alcohol dehydrogenase 2 is a major hepatic enzyme for human retinol metabolism
20. A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond six cycles in patients with glioblastoma (GEINO 14-01)
21. P.201 Genetic variants associated with low dopaminergic activity relate to parameters included in the metabolic syndrome after treatment with antipsychotics
22. EXTENDING ADJUVANT TEMOZOLOMIDE LONGER THAN SIX CYCLES DOESN'T ADD ANY BENEFIT TO GLIOBLASTOMA PATIENTS ACCORDING TO THE RANDOMIZED GEINO-014 TRIAL
23. SEOM clinical guideline of diagnosis and management of low-grade glioma (vol 20, pg 3, 2017)
24. Updated analysis of the national registry of nervous system tumours in Spain (RETSINE). RETSINE: National registry of nervous system tumours of the Spanish research group in neuro-oncology (GEINO) and Spanish infrequent and orphan tumours group (GETHI)
25. P14.58 Extending adjuvant temozolomide longer than six cycles doesn’t add any benefit to glioblastoma patients according to the randomized GEINO-014 TRIAL
26. Corrigendum to: “Estimation of green water footprint of animal feed for beef cattle production in Southern Great Plains” [Water Resour. Ind. 17 (2017) 11–18]
27. AN APPRAISAL OF THE IMPACT ON SURVIVAL OF NEOADJUVANT TREATMENTS DELAYING RADIOTHERAPY IN 'ONLY-BIOPSIED GLIOBLASTOMA' TRIALS CONDUCTED BY THE GEINO GROUP COMPARED TO PATIENTS TREATED WITH THE STUPP'S REGIME. EXPERIENCE OF THE GEINO AND THE GLIOCAT GROUP
28. Impaired survival in resected glioblastoma multiforme patients treated with early chemoradiation
29. Treatment of recurrent glioblastoma (GB) after radiotherapy (RT) and temozolomide (TMZ): A retrospective analysis of the GLIOCAT study
30. Galectin-1 (Gal-1) expression as a prognostic factor in a homogenous cohort of glioblastoma (GB) (Gliocat study)
31. Valor de la PET/TC cerebral con 18 F-fluorocolina en la detección de recurrencias de neoplasias primarias del sistema nervioso central
32. The usefulness of 18 F-fluorocholine PET/CT in the detection of recurrence of central nervous system primary neoplasms
33. P16.03 Is navigated ultrasound the most efficient intraoperative imaging technique?
34. P16.04 Practical application of intraoperative tractography on awake brain surgery
35. Monomeric RNA polymerase I at 4.9 A resolution
36. Ablación mediante microondas de metástasis pulmonar de sarcoma en paciente portador de marcapasos
37. 412P - Updated analysis of the national registry of nervous system tumours in Spain (RETSINE). RETSINE: National registry of nervous system tumours of the Spanish research group in neuro-oncology (GEINO) and Spanish infrequent and orphan tumours group (GETHI)
38. Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a Phase II study
39. Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry (vol 116, pg 413, 2014)
40. MGMT methylated (Met) patients (p) with glioblastoma (GBM) have a better prognosis with an earlier response (ER) than those who have a late response or pseudoprogression (LR/PsP). Results of the Gliocat study
41. Characteristics of gliobastomas (GBM) not resected (only biopsied) homogeneosuly treated with Stupp regimen. Results from the GLIOCAT study
42. Long-term survivors (LTS) in glioblastoma (GBM) patients (pts) homogeneously treated with the Stupp regimen, clinical and molecular characteristics (MGMT and IDH1 status). Initial results from the GLIOCAT study
43. Concomitant chemoradiation (Ch-RT) in elderly newly diagnosed glioblastoma (GB) patients. Updated clinical outcome and molecular characteristics from the GLIOCAT study
44. 388P - Impaired survival in resected glioblastoma multiforme patients treated with early chemoradiation
45. OPTIMIZATION OF THE CROSSFLOW MICROFILTRATION OF ARAZÁ JUICE (Eugenia stipitata) UNDER DIFFERENT OPERATION MODES
46. 2902 GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of Dacomitinib, a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutation
47. Evaluating Nutrient Tracking Tool and simulated conservation practices
48. Nonsurgical Treatment of Recurrent Glioblastoma
49. Stratigraphy, facies analysis and paleoenvironments of the Cañadón Asfalto Formation, Jurassic Cerro cóndor depocenter, Chubut province
50. 330PD - Galectin-1 (Gal-1) expression as a prognostic factor in a homogenous cohort of glioblastoma (GB) (Gliocat study)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.